RobierAAguillon PradaMD
Internal Medicine • Houston, TXCritical Care Medicine, Nephrology
Faculty, Department of Pulmonary and Critical Care Medicine
Dr. Aguillon Prada is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
McGovern Medical School
6431 Fannin St
Houston, TX 77030- Is this information wrong?
Summary
- Dr. Robier Aguillon Prada is an Intensivist and Nephrologist in Houston, TX and is affiliated with The University of Texas Houston McGovern Medical School. He received his medical degree from Industrial University of Santander Faculty of Medicine and has been in practice 14 years. He trained at UCSD, The University of Miami, Duke University and Cleveland Clinic
Education & Training
Cleveland Clinic FoundationFellowship, Critical Care Medicine, 2013 - 2015
Duke University HospitalFellowship, Nephrology, 2011 - 2013
University of Miami/Jackson Health SystemResidency, Internal Medicine, 2008 - 2011
Industrial University of Santander Faculty of MedicineClass of 2003
Certifications & Licensure
TX State Medical License 2021 - 2024
OH State Medical License 2013 - 2023
NC State Medical License 2011 - 2013- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- 1 citationsExercise-induced alterations in phospholipid hydrolysis, airway surfactant, and eicosanoids and their role in airway hyperresponsiveness in asthma.Ryan C. Murphy, Ying Lai, James D. Nolin, Robier Aguillon Prada, Arindam Chakrabarti, Michael Novotny, Michael C. Seeds, William A. Altemeier, Michael H. Gelb, Robert ...> ;American Journal of Physiology. Lung Cellular and Molecular Physiology. 2021 Feb 3
- 50 citationsCanakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-1...Calvin C Sheng, Debasis Sahoo, Siddharth Dugar, Robier Aguillon Prada, Tom Kai Ming Wang, Ossama K. Abou Hassan, Danielle M. Brennan, Daniel A. Culver, Prabalini Rajen...> ;Clinical Cardiology. 2020 Aug 24
- 3 citationsIntratumoral Injection of Ad-ISF35 (Chimeric CD154) Breaks Tolerance and Induces Lymphoma Tumor RegressionMauricio Urquiza, Johanna Melo-Cardenas, R.A. Aguillon, Thomas J. Kipps, Januario E. Castro> ;Human Gene Therapy. 2015 Jan 1
- Join now to see all
Journal Articles
- Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, ...Paul C Cremer 1, Antonio Abbate 2, Kristin Hudock 3, Carla McWilliams 4, Jinesh Mehta 5, Steven Y Chang 6, Calvin C Sheng 1, Benjamin Van Tassell 2, Aldo Bonaventura 2..., Lancet Rheumatol . 2021 Jun;3(6):e410-e418, 3/17/2021
Hospital Affiliations
Memorial Hermann - Texas Medical CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
